Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects. [electronic resource]
Producer: 20060705Description: 590-9 p. digitalISSN:- 0009-9236
- Administration, Oral
- Adult
- Alprazolam -- administration & dosage
- Anti-Anxiety Agents -- administration & dosage
- Area Under Curve
- Asian People -- genetics
- Cytochrome P-450 CYP3A -- genetics
- DNA -- analysis
- DNA Primers
- Genotype
- Humans
- Korea
- Male
- Polymerase Chain Reaction
- Polymorphism, Genetic
- Reference Values
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.